Smad3 deficiency ameliorates experimental obliterative bronchiolitis in a heterotopic tracheal transplantation model

American Journal of Pathology

Volumn 165, Issue 4, 2004, Pages 1223-1232

  Ramirez, Allan M ^a   Takagawa, Shinsuke ^c   Sekosan, Marin ^d   Jaffe, H Ari ^c   Varga, John ^c   Roman, Jesse ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ATLANTA VA MEDICAL CENTER   (United States)

^c UNIVERSITY OF ILLINOIS   (United States)

^d Jr Hospital of Cook County   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; CONNECTIVE TISSUE GROWTH FACTOR; FIBRONECTIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BRONCHIOLITIS; BRONCHIOLITIS OBLITERANS; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CHRONIC GRAFT REJECTION; CONNECTIVE TISSUE; CONTROLLED STUDY; EXPERIMENTAL MODEL; FIBROBLAST CULTURE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; LUNG FIBROBLAST; MONONUCLEAR CELL; MOUSE; MOUSE STRAIN; NONHUMAN; ORGAN TRANSPLANTATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SURVIVAL RATE; TISSUE DISTRIBUTION; TISSUE REPAIR; TRACHEA GRAFT; WESTERN BLOTTING; WILD TYPE;

EID: 4644349675     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63382-2     Document Type: Article

References (37)

1. Trulock EP, Edwards LB, Taylor DO, Boucek MM, Keck BM, Hertz MI: The Registry of the International Society for Heart and Lung Transplantation: twenty-first official adult lung and heart-lung transplant report-2004. J Heart Lung Transplant 2004, 23:804-815
2. Estenne M, Hertz MI: Bronchiolitis obliterans after human lung transplantation. Am J Respir Crit Care Med 2002, 166:440-444
3. Sundaresan S, Trulock EP, Mohanakumar T, Cooper JD, Patterson GA: Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation. Washington University Lung Transplant Group. Ann Thorac Surg 1995, 60:1341-1347
4. Blobe GC, Schiemann WP, Lodish HF: Role of transforming growth factor beta in human disease. N Engl J Med 2000, 342:1350-1358
5. Qin L, Chavin KD, Ding Y, Woodward JE, Favaro JP, Lin J, Bromberg JS: Gene transfer for transplantation. Prolongation of allograft survival with transforming growth factor-beta 1. Ann Surg 1994, 220:508-518
6. Mora BN, Boasquevisque CH, Boglione M, Ritter JM, Scheule RK, Yew NS, Debruyne L, Qin L, Bromberg JS, Patterson GA: Transforming growth factor-beta1 gene transfer ameliorates acute lung allograft rejection. J Thorac Cardiovasc Surg 2000, 119:913-920
7. Yasufuku K, Heidler KM, O'Donnell PW, Smith GN, Cummings OW, Foresman BH, Fujisawa T, Wilkes DS: Oral tolerance induction by type V collagen downregulates lung allograft rejection. Am J Respir Cell Mol Biol 2001, 25:26-34
8. Demirci G, Nashan B, Pichlmayr R: Fibrosis in chronic rejection of human liver allografts: expression patterns of transforming growth factor-TGFbeta1 and TGF-beta3. Transplantation 1996, 62:1776-1783
9. Shihab FS, Yamamoto T, Nast CC, Cohen AH, Noble NA, Gold LI, Border WA: Transforming growth factor-beta and matrix protein expression in acute and chronic rejection of human renal allografts. J Am Soc Nephrol 1995, 6:286-294
10. Aziz T, Hasleton P, Hann AW, Yonan N, Deiraniya A, Hutchinson IV: Transforming growth factor beta in relation to cardiac allograft vasculopathy after heart transplantation. J Thorac Cardiovasc Surg 2000, 119:700-708
11. El-Gamel A, Sim E, Hasleton P, Hutchinson J, Yonan N, Egan J, Campbell C, Rahman A, Sheldon S, Deiraniya A, Hutchinson IV: Transforming growth factor beta (TGF-beta) and obliterative bronchiolitis following pulmonary transplantation. J Heart Lung Transplant 1999, 18:828-837
12. Charpin JM, Valcke J, Kettaneh L, Epardeau B, Stern M, Israel-Biet D: Peaks of transforming growth factor-beta mRNA in alveolar cells of lung transplant recipients as an early marker of chronic rejection. Transplantation 1998, 65:752-755
13. Liu M, Suga M, Maclean AA, St. George JA, Souza DW, Keshavjee S: Soluble transforming growth factor-beta type III receptor gene transfection inhibits fibrous airway obliteration in a rat model of bronchiolitis obliterans. Am J Respir Crit Care Med 2002, 15:419-423
14. Hertz MI, Jessurun J, King MB, Savik SK, Murray JJ: Reproduction of the obliterative bronchiolitis lesion after heterotopic transplantation of mouse airways. Am J Pathol 1993, 142:1945-1951
15. Massague J, Wotton D: Transcriptional control by the TGF-beta/Smad signaling system. EMBO J 2000, 19:1745-1754
16. Taylor LM, Kachigian LM: Induction of PDGF B-chain expression by TGF-β involves transactivation by Smad3. J Biol Chem 2000, 275:16709-16716
17. Holmes A, Abraham DJ, Sa S, Shiwen X, Black CM, Leask A: CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling. J Biol Chem 2001, 276:10594-10601
18. Isono M, Chen S, Hong SW, Iglesias-de la Cruz MC, Ziyadeh FN: Smad pathway is activated in the diabetic mouse kidney and Smad3 mediates TGF-beta-induced fibronectin in mesangial cells. Biochem Biophys Res Commun 2002, 296:1356-1365
19. Chen SJ, Yuan W, Levenson A, Mori Y, Trojanowska M, Varga J: Stimulation of type I collagen transcription in human skin fibroblasts by transforming growth factor-β: involvement of Smad3. J Invest Dermatol 1999, 112:49-57
20. Verrecchia F, Chu ML, Mauviel A: Identification of novel TGF-beta/Smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approach. J Biol Chem 2001, 276:17058-17062
21. Yuan W, Varga J: Transforming growth factor-beta repression of matrix metalloproteinase-1 in dermal fibroblasts involves Smad3. J Biol Chem 2001, 276:38502-38510
22. Yang X, Letterio JJ, Lechleider RJ, Chen L, Hayman R, Gu H, Roberts AB, Deng C: Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta. EMBO J 1999, 18:1280-1291
23. Schacker TW, Nguyen PL, Beilman GJ, Wolinsky S, Larson M, Reilly C, Haase AT: Collagen deposition in HIV-1 infected lymphatic tissues and T cell homeostasis. J Clin Invest 2002, 110:1133-1139
24. Datto MB, Frederick JP, Pan L, Borton AJ, Zhuang Y, Wang XF: Targeted disruption of Smad3 reveals an essential role in transforming growth factor beta-mediated signal transduction. Mol Cell Biol 1999, 19:2495-2504
25. Boehler A, Chamberlain D, Kesten S, Slutsky AS, Liu M, Keshavjee S: Lymphocytic airway infiltration as a precursor to fibrous obliteration in a rat model of bronchiolitis obliterans. Transplantation 1997, 64:311-331
26. Roy F, DeBlois C, Doillon CJ: Extracellular matrix analogs as carriers for growth factors: in vitro fibroblast behavior. J Biomed Mater Res 1993, 27:389-397
27. Piek E, Ju WJ, Heyer J, Escalante-Alcalde D, Stewart CL, Weinstein M, Deng C, Kucherlapati R, Bottinger EP, Roberts AB: Functional characterization of transforming growth factor beta signaling in Smad2- and Smad3-deficient fibroblasts. J Biol Chem 200, 276:19945-19953
28. Kim SJ, Angel P, Lafyatis R, Hattori K, Kim KY, Sporn MB, Karin M, Roberts AB: Autoinduction of transforming growth factor beta 1 is mediated by the AP-1 complex. Mol Cell Biol 1990, 10:1492-1497
29. Brigstock DR: The connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed (CCN) family. Endocr Rev 1999, 20:189-206
30. Blom IE, Goldsohmeding R, Leask A: Gene regulation of connective tissue growth factor: new targets for antifibrotic therapy? Matrix Biol 2002, 21:473-482
31. Lasky JA, Ortiz LA, Tonthat B, Hoyle GW, Corti M, Athas G, Lungarella G, Brody A, Friedman M: Connective tissue growth factor mRNA expression is upregulated in bleomycin-induced lung fibrosis. Am J Physiol 1998, 275:L365-L371
32. Zhao J, Shi W, Wang YL, Chen H, Bringas Jr P, Datto MB, Frederick JP, Wang XF, Warburton D: Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice. Am J Physiol 2002, 282:L585-L593
33. Nakao A, Fujii M, Matsumura R, Kumano K, Saito Y, Miyazono K, Iwamoto I: Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice. J Clin Invest 1999,104(1): 5-11
34. Hocevar BA, Brown TL, Howe PH: TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway. EMBO 1999, 18(5):1345-56
35. Laping NJ, Grygielko E, Mathur A, Butter S, Bomberger J, Tweed C, Martin W, Fornwald J, Lehr R, Marling J, Gaster L, Callahan JF, Olson BA: Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542. Mol Pharmacol 2002, 62:58-64
36. Kallio EA, Koskinen PK, Aavik E, Buchdunger E, Lemstrom KB: Role of platelet-derived growth factor in obliterative bronchiolitis (chronic rejection) in the rat. Am J Respir Crit Care Med 1999, 160:1324-1332 Bowersox JC, Sorgente N: Differential effects of soluble and immobilized fibronectins on aortic endothelial cell proliferation and attachment. In Vitro Cell Dev Biol 1987, 23:759-764
37. Kallio EA, Koskinen PK, Aavik E, Buchdunger E, Lemstrom KB: Role of platelet-derived growth factor in obliterative bronchiolitis (chronic rejection) in the rat. Am J Respir Crit Care Med 1999, 160:1324-1332 Bowersox JC, Sorgente N: Differential effects of soluble and immobilized fibronectins on aortic endothelial cell proliferation and attachment. In Vitro Cell Dev Biol 1987, 23:759-764